PPIs may not reduce cancer risks

Long-term pharmacological gastric acid suppression may not reduce the risk of oesophageal cancer in patients with reflux disease, UK data has suggested.

Comparison of 809 cases of newly diagnosed oesophageal or gastric cancer with 10,000 controls highlighted a five-fold increased risk of oesophageal adenocarcinoma among patients who had taken a proton pump inhibitor (PPI) or H2 blocker for more than three years.  

This risk was only seen in patients with reflux symptoms, oesophagitis, Barrett’s oesophagus or hiatal hernia. Patients with peptic ulcers or gastroduodenal symptoms had no increased risk.  

West Sussex GP Dr Jim Price, a member of the Primary Care Society for Gastroenterology, said the findings were surprising. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led vaccination sites have delivered nearly three quarters of COVID-19 vaccine...

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

Suggestions that vaccination sites should throw away usable doses of COVID-19 vaccine...

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs have been encouraged to use their ‘huge influence’ to bust misinformation around...

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 people aged over 80 in England received a first dose of COVID-19 vaccine...

Summary of changes to the GP contract 2021/22

Summary of changes to the GP contract 2021/22

The BMA and NHS England have agreed minor changes to the GP contract for 2021/22....